Alfred Schweikert Ph.D., Rac

Alfred Schweikert, PhD, RAC has extensive work experience in the field of regulatory affairs and quality assurance. Alfred currently holds the position of Senior Vice President of Regulatory Affairs and Quality Assurance at Enalare Therapeutics Inc., where they are responsible for managing and coordinating regulatory affairs and quality assurance functions. Alfred previously served as Vice President of Regulatory Affairs at Vero Biotech and MonoSol Rx, LLC, where they developed and executed regulatory strategies, collaborated with different departments, and prepared and filed regulatory documents. Alfred also held leadership positions at companies such as Orexo Inc., IKARIA Inc., and Baxter Healthcare Corporation, where they oversaw regulatory activities, developed regulatory strategies, and communicated with global health authorities. Alfred's earlier work experience includes roles at ImClone Systems, Titan Pharmaceuticals, Johnson and Johnson Inc., and Schering Plough Pharmaceutical Inc., where they contributed to various aspects of product development, regulatory submissions, and management. Alfred has a strong background in regulatory compliance and extensive knowledge of global regulatory requirements.

Alfred Schweikert, PhD, RAC has an extensive education history. Alfred obtained their Bachelor of Science (B.Sc.) degree in Biology and Chemistry from West Virginia Wesleyan College, where they studied from 1977 to 1981. Alfred then pursued their Masters study in Microbiology and Immunology at West Virginia University, from 1981 to 1982. Following this, they attended The University of Tennessee Health Science Center from 1983 to 1987, where they earned their Doctor of Philosophy (PhD) in Biochemistry and Microbiology.

In addition to their academic achievements, Schweikert is also certified in Regulatory Affairs by the Regulatory Affairs Professional Society. The specific month and year of obtaining this certification are not provided.